TREELINE BIOSCIENCES
Live / Registered — Registered (as of 25 Nov 2025)
What this means for you
Registered since 25 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90981524
- Registration number
- 8042862
- Mark type
- Stylized text
- Filed
- 22 Apr 2021
- Published for opposition
- 21 Mar 2023
- Registered
- 25 Nov 2025
- Attorney of record
- Caitlin R. Byczko
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products, namely, preparations for the prevention and treatment of cancer, lymphomas
- Class 042 — Scientific and technological services: pharmaceutical research and development in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; medical, pharmaceutical, and scientific research in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; medical, pharmaceutical, and scientific research in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; clinical research and testing services not for medical diagnostic purposes in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders
Owner
- Treeline Biosciences, Inc., Watertown, MA, US
- Treeline Biosciences, Inc., Watertown, MA, US
- Treeline Biosciences, Inc., Stamford, CT, US
Prosecution history
- 25 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 06 Nov 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Nov 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 16 May 2025 — USE AMENDMENT FILED
- 31 Oct 2025 — DIVISIONAL PROCESSING COMPLETE
- 17 Jan 2025 — DIVISIONAL REQUEST RECEIVED
- 30 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2025 — SOU EXTENSION 4 GRANTED
- 15 May 2025 — SOU EXTENSION 4 FILED
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jan 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 14 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED